{"id":190230,"date":"2024-05-28T02:22:57","date_gmt":"2024-05-28T07:22:57","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/05\/stem-cells-lab-grown-meat-and-potential-new-medical-treatments-with-mark-kotter"},"modified":"2024-05-28T02:22:57","modified_gmt":"2024-05-28T07:22:57","slug":"stem-cells-lab-grown-meat-and-potential-new-medical-treatments-with-mark-kotter","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/05\/stem-cells-lab-grown-meat-and-potential-new-medical-treatments-with-mark-kotter","title":{"rendered":"Stem cells, lab-grown meat, and potential new medical treatments, with Mark Kotter"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/zDA6KmRe19c?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Our guest in this episode is Dr. Mark Kotter. Mark is a neurosurgeon, stem cell biologist, and founder or co-founder of three biotech start-up companies that have collectively raised hundreds of millions of pounds: bit.bio, clock.bio, and Meatable.<\/p>\n<p>In addition, Mark still conducts neurosurgeries on patients weekly at the University of Cambridge.<\/p>\n<p>We talk to Mark about all his companies, but we start by discussing Meatable, one of the leading companies in the cultured meat sector. This is an area of technology which should have a far greater impact than most people are aware of, and it\u2019s an area we haven\u2019t covered before in the podcast.<\/p>\n<p>Selected follow-ups:<\/p>\n<p>\u2022 Dr Mark Kotter at the University of Cambridge (<a href=\"https:\/\/www.stemcells.cam.ac.uk\/peopl\">https:\/\/www.stemcells.cam.ac.uk\/peopl<\/a>\u2026)<br \/> \u2022 Meatable (<a href=\"https:\/\/meatable.com\/\">https:\/\/meatable.com\/<\/a>)<br \/> \u2022 bit.bio (<a href=\"https:\/\/www.bit.bio\/\">https:\/\/www.bit.bio\/<\/a>)<br \/> \u2022 clock.bio (<a href=\"https:\/\/clock.bio\/\">https:\/\/clock.bio\/<\/a>)<br \/> \u2022 After 25 years of hype, embryonic stem cells are still waiting for their moment (<a href=\"https:\/\/www.technologyreview.com\/2023\">https:\/\/www.technologyreview.com\/2023<\/a>\u2026) \u2014 Article in MIT Technology Review.<br \/> \u2022 The Nobel Prize in Physiology or Medicine 2012 (<a href=\"https:\/\/www.nobelprize.org\/prizes\/med\">https:\/\/www.nobelprize.org\/prizes\/med<\/a>\u2026)<br \/> \u2022 Moo\u2019s Law: An Investor\u2019s Guide to the New Agrarian Revolution (<a href=\"https:\/\/www.harriman-house.com\/mooslaw\">https:\/\/www.harriman-house.com\/mooslaw<\/a>) \u2014 book by Jim Mellon.<br \/> \u2022 What is the climate impact of eating meat and dairy? (<a href=\"https:\/\/interactive.carbonbrief.org\/w\">https:\/\/interactive.carbonbrief.org\/w<\/a>\u2026)<br \/> \u2022 Guidance for businesses on cell-cultivated products and the authorisation process (<a href=\"https:\/\/www.food.gov.uk\/business-guid\">https:\/\/www.food.gov.uk\/business-guid<\/a>\u2026)<br \/> \u2022 Wild mammals make up only a few percent of the world\u2019s mammals (<a href=\"https:\/\/ourworldindata.org\/wild-mamma\">https:\/\/ourworldindata.org\/wild-mamma<\/a>\u2026) \u2014 Our World In Data.<br \/> \u2022 BlueRock Therapeutics (<a href=\"https:\/\/www.bluerocktx.com\/\">https:\/\/www.bluerocktx.com\/<\/a>)<br \/> \u2022 Therapies under development at bit.bio (<a href=\"https:\/\/www.bit.bio\/therapeutics2023\">https:\/\/www.bit.bio\/therapeutics2023<\/a>)<br \/> \u2022 Stem Cell Gene Therapy Shows Promise in ALS Trial (<a href=\"https:\/\/www.technologynetworks.com\/ne\">https:\/\/www.technologynetworks.com\/ne<\/a>\u2026) \u2014 from Cedars-Sinai Medical Center.<\/p>\n<p>Music: Spike Protein, by Koi Discovery, available under CC0 1.0 Public Domain Declaration.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2024\/05\/stem-cells-lab-grown-meat-and-potential-new-medical-treatments-with-mark-kotter\">Continue reading \u201cStem cells, lab-grown meat, and potential new medical treatments, with Mark Kotter\u201d | &gt;<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Our guest in this episode is Dr. Mark Kotter. Mark is a neurosurgeon, stem cell biologist, and founder or co-founder of three biotech start-up companies that have collectively raised hundreds of millions of pounds: bit.bio, clock.bio, and Meatable. In addition, Mark still conducts neurosurgeries on patients weekly at the University of Cambridge. We talk to [\u2026]<\/p>\n","protected":false},"author":661,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,1506],"tags":[],"class_list":["post-190230","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-food"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/190230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/661"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=190230"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/190230\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=190230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=190230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=190230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}